CN1849328A - 新型14和15元环化合物 - Google Patents

新型14和15元环化合物 Download PDF

Info

Publication number
CN1849328A
CN1849328A CNA2004800192646A CN200480019264A CN1849328A CN 1849328 A CN1849328 A CN 1849328A CN A2004800192646 A CNA2004800192646 A CN A2004800192646A CN 200480019264 A CN200480019264 A CN 200480019264A CN 1849328 A CN1849328 A CN 1849328A
Authority
CN
China
Prior art keywords
alkyl
group
hydrogen
ethyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800192646A
Other languages
English (en)
Chinese (zh)
Inventor
S·阿利霍兹克
A·K·福雷斯特
R·L·亚维斯特
G·拉扎雷夫斯基
D·帕夫洛维克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Fidelta doo
Original Assignee
Glaxo Group Ltd
Pliva Istrazivacki Institut doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Istrazivacki Institut doo filed Critical Glaxo Group Ltd
Publication of CN1849328A publication Critical patent/CN1849328A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNA2004800192646A 2003-05-13 2004-05-11 新型14和15元环化合物 Pending CN1849328A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0310986.5A GB0310986D0 (en) 2003-05-13 2003-05-13 Novel compounds
GB0310986.5 2003-05-13

Publications (1)

Publication Number Publication Date
CN1849328A true CN1849328A (zh) 2006-10-18

Family

ID=9957984

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800192646A Pending CN1849328A (zh) 2003-05-13 2004-05-11 新型14和15元环化合物

Country Status (22)

Country Link
US (1) US7569550B2 (enExample)
EP (1) EP1628988B1 (enExample)
JP (1) JP2007502313A (enExample)
KR (1) KR20060026407A (enExample)
CN (1) CN1849328A (enExample)
AR (1) AR044309A1 (enExample)
AT (1) ATE341560T1 (enExample)
AU (1) AU2004238528A1 (enExample)
BR (1) BRPI0410246A (enExample)
CA (1) CA2525452A1 (enExample)
CL (1) CL2004001010A1 (enExample)
DE (1) DE602004002696T2 (enExample)
DK (1) DK1628988T3 (enExample)
ES (1) ES2273255T3 (enExample)
GB (1) GB0310986D0 (enExample)
HR (1) HRP20060448T3 (enExample)
MX (1) MXPA05012163A (enExample)
PL (1) PL1628988T3 (enExample)
PT (1) PT1628988E (enExample)
RU (1) RU2005134908A (enExample)
WO (1) WO2004101586A1 (enExample)
ZA (1) ZA200509079B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111574575A (zh) * 2020-04-29 2020-08-25 北京理工大学 一种含有大环内酯基的喹喏酮衍生物、制备方法及应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
EP1851236B1 (en) * 2005-01-13 2010-08-04 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Macrolides with anti-inflammatory activity
WO2006120541A1 (en) * 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
PE20070802A1 (es) * 2005-11-09 2007-10-19 Glaxo Group Ltd Derivados de eritromicina 4''-sustituidos como agentes antimicrobianos
EP1945652A1 (en) * 2005-11-09 2008-07-23 Glaxo Group Limited Macrolones
EP2384333B1 (en) 2009-01-30 2013-04-17 Glaxo Group Limited Anti-inflammatory macrolide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE128714T1 (de) * 1989-03-28 1995-10-15 Abbott Lab Erythromycinderivate.
WO1996034007A1 (es) * 1995-04-27 1996-10-31 Laboratorios Aranda, S.A. De C.V. Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen
CA2253451A1 (en) * 1996-05-07 1997-11-13 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
WO2003014136A1 (en) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111574575A (zh) * 2020-04-29 2020-08-25 北京理工大学 一种含有大环内酯基的喹喏酮衍生物、制备方法及应用
CN111574575B (zh) * 2020-04-29 2022-05-17 北京理工大学 一种含有大环内酯基的喹喏酮衍生物、制备方法及应用

Also Published As

Publication number Publication date
US20070185117A1 (en) 2007-08-09
ATE341560T1 (de) 2006-10-15
AR044309A1 (es) 2005-09-07
CA2525452A1 (en) 2004-11-25
HRP20060448T3 (hr) 2007-03-31
GB0310986D0 (en) 2003-06-18
EP1628988A1 (en) 2006-03-01
MXPA05012163A (es) 2006-05-19
CL2004001010A1 (es) 2005-03-18
RU2005134908A (ru) 2006-06-27
DE602004002696T2 (de) 2007-08-16
PL1628988T3 (pl) 2007-03-30
ES2273255T3 (es) 2007-05-01
AU2004238528A1 (en) 2004-11-25
DK1628988T3 (da) 2007-02-05
ZA200509079B (en) 2007-02-28
DE602004002696D1 (de) 2006-11-16
WO2004101586A1 (en) 2004-11-25
EP1628988B1 (en) 2006-10-04
KR20060026407A (ko) 2006-03-23
BRPI0410246A (pt) 2006-05-16
JP2007502313A (ja) 2007-02-08
US7569550B2 (en) 2009-08-04
PT1628988E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
CN1216064C (zh) 6－o－取代的红霉素衍生物的制备方法
CN1310934C (zh) 可用作抗菌剂的红霉素6－o－氨基甲酰基酮内酯衍生物
CN1081624C (zh) 苯甲酰胺类似物,用作parp(adp－核糖基转移酶,adrpt)dna修复酶抑制剂
CN1612888A (zh) 大环内酯类化合物
CN1237183A (zh) 具有抗细菌活性的6－0－取代的酮基内酯类化合物
CN1674898A (zh) 作为促旋酶和 /或拓扑异构酶 i v的抑制剂用于治疗细菌感染的 2 －脲基－6－杂芳基－3 h－苯并咪唑－4－羧酸衍生物和相关化合物
CN1065069A (zh) 新的红霉素衍生物的制备方法
CN1659178A (zh) 6、11二环红霉素衍生物
CN1234031A (zh) 吲唑衍生物及其作为磷酸二酯酶(pde)iv型和肿瘤坏死因子(tnf)产生的抑制剂的应用
CN1244202A (zh) 三环红霉素衍生物
CN1337950A (zh) 2－氧代喹啉化合物及其药物用途
CN1678620A (zh) 具有抗炎活性的大环内酯化合物
CN1434830A (zh) 2－氨基羰基－9h－嘌呤衍生物
CN1072219C (zh) 二氮杂䓬酮、其生产和用途
CN1151746A (zh) 新的红霉素衍生物、其制备方法及其作为药物的应用
CN1281439A (zh) 用作抗病毒剂的4－羟基喹啉－3－甲酰胺和酰肼化合物
CN1446218A (zh) 苯并咪唑衍生物,它们的制备方法以及它们的治疗应用
CN1671690A (zh) 抗微生物的氮杂二环衍生物、它们的组合物及用途
CN1240707C (zh) 2－卤代－6－0－取代的酮内酯衍生物
CN1238777A (zh) 红霉素a衍生物
CN1048242C (zh) 5-氨基-8-甲基-7-吡咯烷喹啉-3-羧酸衍生物及其制造方法和中间体化合物
CN1633444A (zh) 6－11双环酮大环内酯衍生物
CN1343215A (zh) 具有抗菌活性的6－o－取代大环内酯类化合物
CN1867570A (zh) 作为抗感染试剂的异噻唑喹诺酮及其相关化合物
CN1849328A (zh) 新型14和15元环化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20061018